[1]申雅静,冯晨露,路　平.雷公藤内酯醇联合顺铂对食管鳞癌细胞ECA-109增殖的影响[J].新乡医学院学报,2016,33(10):864-867.[doi:10.7683/xxyxyxb.2016.10.007]
　SHEN Ya-jing,FENG Chen-lu,LU Ping.Effect of triptolide combined with cisplatin on proliferation of esophageal cancer ECA-109 cells[J].Journal of Xinxiang Medical University,2016,33(10):864-867.[doi:10.7683/xxyxyxb.2016.10.007]
点击复制

雷公藤内酯醇联合顺铂对食管鳞癌细胞ECA-109增殖的影响
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
33
期数:
2016年10
页码:
864-867
栏目:
基础研究
出版日期:
2016-10-05

文章信息/Info

Title:
Effect of triptolide combined with cisplatin on proliferation of esophageal cancer ECA-109 cells
作者:
申雅静; 冯晨露; 路　平
(新乡医学院第一附属医院肿瘤科，河南　卫辉　453100）
Author(s):
SHEN Ya-jing; FENG Chen-lu; LU Ping
(Department of Oncology,the First Affiliated Hospital of Xinxiang Medical University,Weihui 453100,Henan Province,China)
关键词:
雷公藤内酯醇; 顺铂; 食管鳞癌细胞; 半胱氨酸天冬氨酸特异性蛋白酶-3
Keywords:
triptolide; cisplatin; esophageal cancer cell; caspase-3
分类号:
R735.1
DOI:
10.7683/xxyxyxb.2016.10.007
文献标志码:
A
摘要:
目的　观察雷公藤内酯醇（TPL）以及TPL联合顺铂对人食管鳞癌细胞ECA-109增殖的影响，并探讨其作用机制。方法　选取对数生长期的人ECA-109细胞，随机分为空白对照组（不经药物处理）、不同浓度（6.25、12.50、25.00、50.00、100.00 μg·L-1）TPL组、4.17 μmol·L-1顺铂组、TPL（25.00 μg·L-1）联合顺铂（4.17 μmol·L-1）组；采用四甲基偶氮唑蓝法测定各组不同时间段（24、48、72 h）的细胞增殖抑制率，并计算TPL与顺铂之间的交互作用；采用Western blot检测空白对照组、25.00 μg·L-1TPL处理组、4.17 μmol·L-1顺铂组、TPL联合顺铂组细胞培养24 h后半胱氨酸天冬氨酸特异性蛋白酶-3（caspase-3）的表达。结果　同一时间点，不同浓度TPL组对ECA-109细胞增殖的抑制率显著高于空白对照组（P<0.05），且呈剂量依赖性（P<0.05）；同一药物浓度条件下，随作用时间延长，细胞增殖抑制率显著增加（P<0.05），即呈时间依赖性。同一时间点，TPL联合顺铂组对ECA-109的抑制率高于同药物浓度条件下单用顺铂或单用TPL对细胞增殖的抑制率（P<0.05）。加药培养24 h后，TPL组、顺铂组及TPL联合顺铂组caspase-3蛋白表达量均显著高于空白对照组（P<0.05），且TPL联合顺铂组caspase-3蛋白表达量高于同药物浓度条件下单用TPL组、单用顺铂组蛋白表达量（P<0.05）。结论　TPL具有抑制食管癌ECA-109细胞增殖的作用，TPL联合顺铂有协同作用，增加对食管癌ECA-109细胞的抑制，其机制可能与促进caspase-3蛋白表达有关。
Abstract:
Objective　To observe the effect of triptolide combined with cisplatin on proliferation of esophageal cancer ECA-109 cells and to explore its potential mechanisms.Methods　ECA-109 cells in exponential phase of growth were randomly divided into blank control group,triptolide group (6.25,12.50,25.00,50.00,100.00 μg·L-1),4.17 μmol·L-1 cisplatin group and TPL+cisplatin group (25.00 μg·L-1triptolide + 4.17 μmol·L-1 cisplatin).Methylthiazolyl tetrazolium method was used to evaluate the cell proliferation inhibition rate in each group at different time(24,48,72 h) and the interaction between TPL and cisplatin was calculated.Western blot was used to detect the expression of cysteinyl aspartate specific proteinase-3(caspase-3） in blank control group,25.00 μg·L-1 TPL group,cisplatin group and TPL+cisplatin group after being cultured for 24 hours.Results　The proliferation inhibition rates were significantly higher in the different concentration triptolide groups than those in blank control group at the same time point（P<0.05），and the proliferation inhibition rate in triptolide group was concentration dependent（P<0.05）;at the same drug concentration,the proliferation inhibition rates in the different concentration triptolide groups were increased with the time,it showed time dependent（P<0.05）.At the same time point,the proliferation inhibition rate in TPL+cisplatin group was significantly higher than that in different concentration triptolide group and cisplatin group（P<0.05）.After being cultured for 24 h,the expression of caspase-3 in triptolide group,cisplatin group and TPL+cisplatin group was obviously higher than that in the blank control group.Besides,the expression of caspase-3 in TPL+cisplatin group was significantly higher than that in triptolide group and cisplatin group（P<0.05）.Conclusion　Triptolide,as well as combined with cisplatin,can inhibit the proliferation of esophageal cancer ECA-109 cells,and its potential mechanism might be involved in promoting the expression of caspase-3 protein.

参考文献/References:

［1］　SIEGEL R,WARD E,BRAWLEY O,et al.Cancer statistics，2011:the impact of eliminating socioeconomic and racial disparities on premature cancer deaths［J］.CA Cancer J Clin,2011,61(4):212-236.
［2］　李玮浩,赵松,崔广晖.食管癌患者术前行新辅助化学治疗相关危险因素分析［J］.新乡医学院学报,2013,30(7)：384-385.
［3］　BORJA-CACHO D,YOKOYAMA Y,CHUGH R K,et al.TRAIL and triptolide:an effective combination that induces apoptosis in pancreatic cancer cells［J］.J Gastrointest Surg,2009,14(2):252-260.
［4］　YANG S W，WANG W，XIE X Y,et al.In vitro synergistic cytotoxic effect of triptolide combined with hydroxycamptothecin on pancreatic cancer cells［J］.Am J Chin Med，2011,39(1):121-134.
［5］　ZHU W,LI J,WU S,et al.Triptolide cooperates with Cisplatin to induce apoptosis in gemcitabine-resistant pancreatic cancer［J］.Pancreas,2012,41(7):1029-1038.
［6］　张效文,严名,王芷芬,等.用Q值估计合并用药效果的新方法：“双30法”［J］.上海第二医学院学报，1985，5(5):353-354.
［7］　JEMAL A,BRAY F,CENTER M M,et al.Global cancer statistics［J］.CA Cancer J Clin,2011,61(2):69-90.
［8］　杨旭光,徐晓煜,李家璜,等.雷公藤内酯醇靶蛋白的筛选及其结合的初步验证［J］.分析化学,2012,40(3):365-370.
［9］　LIU Q.Triptolide and its expanding multiple pharmacological functions［J］.Int Immunopharmacol，2011,11(3):377-383.
［10］　刘娜,刘铭耀,李晔.雷公藤内酯醇体内外实验研究进展［J］.海峡药学,2015,27(12):99-101.
［11］　朱四红.雷公藤内酯醇联合紫杉醇对人卵巢癌耐顺铂细胞株体外活性影响及机制的研究［J］.山东医药,2011,51(47):15-17.
［12］　王恒邦，许建华,温彩霞,等.雷公藤内酯醇体内外抗肿瘤作用［J］.福建医科大学学报，2007，41(4):304-307.
［13］　PIGNEUX A,MAHON F X,UHALDE M,et al.Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells［J］.Exp Hematol,2008,36(12):1648-1659.
［14］　WOLF B B,GREEN D R.Suicidal tendencies:apoptotic cell death by caspase family proteinases［J］.J Biol Chem,1999,274(29):20049-20052.
［15］　孙运良,吴红玉,金晶,等.雷公藤内酯醇联合吉西他滨对胰腺癌细胞增殖和凋亡的影响［J］.重庆医学,2014(5):578-581.

相似文献/References:

[1]牛红蕊,袁 亮,吴随群.羟基喜树碱联合顺铂和足叶乙甙治疗中晚期非小细胞肺癌39例[J].新乡医学院学报,2002,19(05):419.
[2]赫鸿昌.异长春花碱联合顺铂治疗晚期非小细胞肺癌l7例[J].新乡医学院学报,2003,20(02):126.
[3]赫鸿昌.异长春花碱联合顺铂治疗晚期非小细胞肺癌17 例[J].新乡医学院学报,2003,20(02):126.
[4]张海君,闫卫东,邝先奎.目的从伦理学的角度来思考基因歧视产生的原因和所引起的危害，并寻求对策。方法查阅并分析近1O年的文献。结果导致基因歧视产生的理论观点是不正确的，这种现象对人类有极大的危害，人们可以通过对隐私权的保护来避免或减轻它对人类的伤害。结论 基因歧视是不公正也是不[J].新乡医学院学报,2003,20(06):428.
[5]刘　星,刘思源,刘晓钰.顺铂与卡铂对骨肉瘤细胞株作用的分子机制[J].新乡医学院学报,2016,33(5):373.[doi:10.7683/xxyxyxb.2016.05.008]
　LIU Xing,LIU Si-yuan,LIU Xiao-yu.Molecular mechanism of cisplatin and carboplatin on osteosarcoma cell line[J].Journal of Xinxiang Medical University,2016,33(10):373.[doi:10.7683/xxyxyxb.2016.05.008]
[6]刘　勇,张艳莉,刘　岩.培美曲塞联合顺铂治疗晚期非小细胞肺癌疗效观察[J].新乡医学院学报,2015,32(09):874.
[7]杨艳荣.培美曲塞与吉西他滨联合顺铂治疗晚期肺腺癌疗效及安全性比较[J].新乡医学院学报,2015,32(12):1103.
[8]李　萍,姬白嫣,魏　娟,等.藏红花素对人宫颈癌Hela细胞顺铂耐药性的影响[J].新乡医学院学报,2021,38(5):401.[doi:10.7683/xxyxyxb.2021.05.001]
　LI Ping,JI Baiyan,WEI Juan,et al.Effect of crocin on cisplatin resistance of human cervical cancer Hela cells[J].Journal of Xinxiang Medical University,2021,38(10):401.[doi:10.7683/xxyxyxb.2021.05.001]
[9]肖琳琳,蔡丽芳.重组人血管内皮抑制素与顺铂交替灌注治疗恶性胸腹腔积液近期疗效观察[J].新乡医学院学报,2016,33(7):632.[doi:10.7683/xxyxyxb.2016.07.023]
　XIAO Lin-lin,CAI Li-fang.Short-term effect of recombinant human endostatin and cisplatin alternating perfusion in treatment of malignant pleural effusion or seroperitoneum[J].Journal of Xinxiang Medical University,2016,33(10):632.[doi:10.7683/xxyxyxb.2016.07.023]
[10]陈利娟,穆晓倩,刘　杰,等.PTEN通过磷脂酰肌醇-3-激酶/蛋白激酶B信号通路对非小细胞肺癌顺铂敏感性的影响[J].新乡医学院学报,2020,37(6):501.[doi:10.7683/xxyxyxb.2020.06.001]
　CHEN Lijuan,MU Xiaoqian,LIU Jie,et al.Effect of PTEN on the sensitivity of non-small cell lung cancer to cisplatin through the phosphatidylinositol-3-kinase/protein kinase B signaling pathway[J].Journal of Xinxiang Medical University,2020,37(10):501.[doi:10.7683/xxyxyxb.2020.06.001]

更新日期/Last Update: 2016-10-05